Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis

被引：0
|
作者：
A.S. Koldkjær Sølling
T. Harsløf
B. Langdahl
机构：
[1] Aarhus University Hospital,Department of Endocrinology and Internal Medicine
来源：
Osteoporosis International | 2019年 / 30卷
关键词：
Bone turnover markers; Cathepsin K inhibitor; Odanacatib; Osteoporosis; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：995 / 1002
页数：7
相关论文
共 50 条
  • [1] Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis
    Solling, A. S. Koldkjaer
    Harslof, T.
    Langdahl, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (05) : 995 - 1002
  • [2] ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Yureneva, S. V.
    Yureneva, S. V.
    Yakushevskaya, O. V.
    Smetnik, V. P.
    Sukchich, G. T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 385 - 385
  • [3] Treatment of postmenopausal osteoporosis with odanacatib
    Chapurlat, Roland D.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (04) : 559 - 564
  • [4] Zoledronic acid prevents bone loss
    Ahmad, Khabir
    [J]. LANCET ONCOLOGY, 2007, 8 (05): : 375 - 375
  • [5] Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women
    Luis Perez-Castrillon, Jose
    Pinacho, Florentino
    De Luis, Daniel
    Lopez-Menendez, Maria
    Duenas Laita, Antonio
    [J]. JOURNAL OF OSTEOPOROSIS, 2010, 2010
  • [6] Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis
    Ma Chao
    Qin Hua
    Zhou Yingfeng
    Wan Guang
    Shi Shufeng
    Dong Yuzhen
    Wang Wei
    Tan Haifeng
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (06) : 1381 - 1384
  • [7] Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis
    McClung, MR
    Wasnich, RD
    Recker, R
    Cauley, JA
    Chesnut, CH
    Ensrud, KE
    Burdeska, A
    Mills, T
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (01) : 11 - 18
  • [8] Daily oral ibandronate prevents bone loss in postmenopausal women without osteoporosis.
    McClung, M
    Wasnich, RD
    Recker, R
    Cauley, JA
    Ensrud, K
    Burdeska, A
    Mahoney, P
    Hughes, C
    Chesnut, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S157 - S157
  • [9] EFFICACY AND SAFETY OF ZOLEDRONIC ACID IN CHINESE WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Huang, L.
    Shen, Y. H.
    Liu, X.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S820 - S821
  • [10] The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis
    Jawl-Shan Hwang
    Lin-Show Chin
    Jung-Fu Chen
    Tzay-Shing Yang
    Po-Quang Chen
    Keh-Sung Tsai
    Ping Chung Leung
    [J]. Journal of Bone and Mineral Metabolism, 2011, 29 : 328 - 333
12345